SCHEMBL8520779

SCHEMBL8520779

Cc1c(SCCCN2CCN(c3ccccn3)CC2)ccnc1CSc1nc2ccccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 3/20 0.51
TNKS O95271 1/20 0.50
PARP1 P09874 1/20 0.50
TNKS2 Q9H2K2 1/20 0.50
PARP2 Q9UGN5 1/20 0.50
DRD2 P14416 4/20 0.49
DRD3 P35462 3/20 0.49
CYP3A4 P08684 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ALOX15 P16050 1/20 0.47
OPRK1 P41145 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
RAB9A P51151 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
NPC1 O15118 1/20 0.47
HTR1A P08908 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8520672 0.92 RAB9A (0.49) DRD4DRD2DRD3CYP3A4RAB9A
SCHEMBL8916879 0.87 RAB9A (0.60) CYP3A4ALDH1A1ALOX15RAB9ACYP1A2
SCHEMBL8812118 0.83 RAB9A (0.44) CYP3A4ALDH1A1RAB9ACYP1A2CYP2D6
SCHEMBL8915325 0.82 RAB9A (0.55) CYP3A4ALDH1A1RAB9ACYP1A2CYP2D6
SCHEMBL8412992 0.82 NPC1 (0.60) CYP3A4ALDH1A1RAB9ACYP1A2CYP2D6
SCHEMBL8915606 0.82 RAB9A (0.69) CYP3A4ALDH1A1ALOX15RAB9ACYP1A2
SCHEMBL8915135 0.82 RAB9A (0.54) CYP3A4RAB9ACYP1A2CYP2D6CYP2C9
SCHEMBL7812340 0.80 NPC1 (0.54) CYP3A4ALDH1A1RAB9ACYP1A2CYP2D6
SCHEMBL7812118 0.80 NPC1 (0.56) CYP3A4ALDH1A1ALOX15RAB9ACYP1A2
SCHEMBL7807341 0.80 NPC1 (0.58) CYP3A4ALDH1A1ALOX15RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5922720-A PHARMACEUTICAL FOR USE IN TREATMENT OF DISEASES BASED ON HELICOBACTER BACTERIA BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-07-13 US disclosed